[Hiring] LATAM/SA Regional Sales Manager @Psomagen, Inc.

Role Description

As a key contributor to the commercial team, the Regional Sales Manager for LATAM North will manage and grow Psomagen's customer base in the region while promoting Psomagen's research genomic, transcriptomic, and proteomic services. Focusing primarily on the Academic, Government, and Biotech sectors, this engagement works cross-functionally to retain existing accounts and develop new ones, driving revenue across Mexico, Central America, and the Caribbean. The ideal contractor will have a solid understanding of NGS markets and the ability to seamlessly manage cross-border sample logistics to our laboratories in the US or South Korea.

This is a remote engagement based in Mexico and may be performed anywhere within the same time zones (GMT-5 to GMT-8); Mexico City or Monterrey preferred.

Engagement Type

This is an independent-contractor engagement under a service agreement, not an offer of employment. The contractor renders the services described below as an independent party and is responsible for their own taxes, statutory contributions, and any applicable local registrations. The contractor reports to the designated Psomagen manager and submits periodic activity reports specifying the services rendered.

Account Types

• Inherited Accounts: Existing customer accounts that are assigned to the contractor at the start of, or during, the engagement. The contractor's responsibility for these accounts is to retain them, ensure continuity of service, and grow their ongoing volume.
• Self-Developed Accounts: New customer accounts that the contractor independently identifies, develops, and closes within the designated territory.

Responsibilities

• Manage and retain the inherited accounts within the designated territory, ensuring continuity of service and growth of ongoing volume.
• Identify, qualify, and close self-developed (new) accounts at academic institutions, government research centers, and local biotech companies.
• Promote Psomagen's research genomic, transcriptomic, and proteomic services, primarily within the Academic, Government, and Biotech sectors, through face-to-face visits and visual communication methods.
• Build and maintain high-level relationships with customer accounts, and develop appropriate business relationships with principal investigators (PIs), decision-makers, and influencers.
• Maintain accurate, up-to-date account and contact details within Psomagen's CRM (HubSpot).
• Advise local researchers on where to send their biological samples (e.g., DNA, RNA, tissues) — to Psomagen's laboratories in the US or South Korea as applicable — and inform them of the relevant customs precautions in accordance with the shipping instructions provided by Psomagen.
• Provide regular and accurate sales-forecast updates, including billed and in-process customer projects.

Fee Structure

• Base Service Fee (time-based): A fee for time worked on the engagement. Where the fee is paid on an hourly basis, the contractor is required to submit a timesheet reporting the hours worked.
• Inherited-Account Incentive (retention & growth): An incentive tied to the retention and continued growth of the inherited accounts.
• Self-Developed-Account Incentive (new business): An incentive tied to net-new revenue from accounts the contractor originates independently.

Qualifications

• Bachelor's degree in a Life Sciences–related major (Biology, Chemistry, Genetics, etc.).
• 3+ years of experience in direct sales and/or marketing of NGS services or molecular-biology products.
• Native or bilingual proficiency in Spanish and professional fluency in English.
• Ability to relay Psomagen's shipping and customs instructions to customers accurately.

Preferred Qualifications

• Master's or Ph.D. in a science field a plus.
• Strong understanding of public-tender processes (Licitaciones) and research-grant cycles in Mexico.

Company Description

Psomagen, Inc., founded in 2004 in Rockville, MD, is at the forefront of genetic and genomic testing. The company offers cutting-edge genomic services through next-generation and Sanger sequencing with data-analysis services for applications in basic research and clinical diagnostics.

Listed on the KOSDAQ in July 2020, the company is rapidly expanding its business from B2B to B2C and from Research to Clinical markets.